Will long-acting glucagon-like peptide-1 analogues recapitulate our agonizing experience with cyclic AMP-dependent positive inotropic agents in heart failure?

Milton Packer

doi:10.1002/ejhf.1047

Will long-acting glucagon-like peptide-1 analogues recapitulate our agonizing experience with cyclic AMP-dependent positive inotropic agents in heart failure?

Milton Packer

Clinical Sciences

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Original language	English (US)
Pages (from-to)	627-629
Number of pages	3
Journal	European Journal of Heart Failure
Volume	20
Issue number	4
DOIs	https://doi.org/10.1002/ejhf.1047
State	Published - Apr 2018

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1002/ejhf.1047

Cite this

@article{7231c047fe6b40a4bab4c0d6be93db5f,

title = "Will long-acting glucagon-like peptide-1 analogues recapitulate our agonizing experience with cyclic AMP-dependent positive inotropic agents in heart failure?",

author = "Milton Packer",

year = "2018",

month = apr,

doi = "10.1002/ejhf.1047",

language = "English (US)",

volume = "20",

pages = "627--629",

journal = "European Journal of Heart Failure",

issn = "1388-9842",